Fora Capital, LLC Veracyte, Inc. Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $196,335 - $359,292	-4,415 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$32.49 - $61.88 $111,765 - $212,867	3,440 Added 352.82%	4,415 $216,000
Q3 2020 Nov 13, 2020	BUY	$26.73 - $35.67 $26,061 - $34,778	975 New	975 $32 Million
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $49,407 - $71,258	-2,535 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$16.13 - $30.17 $40,889 - $76,480	2,535 New	2,535 $61,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.